DKSH

ROCHE THAILAND LTD

Featured products of Roche
tocilizumab
Packing/Price
(vial) 1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
tocilizumab
Packing/Price
(vial) 1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
tocilizumab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
alectinib
Packing/Price
224's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01ED03 - alectinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC07 - bevacizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
mycophenolate mofetil
Packing/Price
100's
MIMS Class
Immunosuppressants
ATC Classification
L04AA06 - mycophenolic acid : Belongs to the class of selective immunosuppressive agents. Used to induce immunosuppression.
mycophenolate mofetil
Packing/Price
50's
MIMS Class
Immunosuppressants
ATC Classification
L04AA06 - mycophenolic acid : Belongs to the class of selective immunosuppressive agents. Used to induce immunosuppression.
obinutuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC15 - obinutuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
emicizumab
Packing/Price
1's
MIMS Class
Haemostatics
ATC Classification
B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.
emicizumab
Packing/Price
1's
MIMS Class
Haemostatics
ATC Classification
B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.
emicizumab
Packing/Price
1's
MIMS Class
Haemostatics
ATC Classification
B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.
emicizumab
Packing/Price
1's
MIMS Class
Haemostatics
ATC Classification
B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC03 - trastuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC03 - trastuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC03 - trastuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
trastuzumab emtansine
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC14 - trastuzumab emtansine : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
trastuzumab emtansine
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC14 - trastuzumab emtansine : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
rituximab
Packing/Price
(vial) 2 × 1's
MIMS Class
Targeted Cancer Therapy, Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
ATC Classification
L01XC02 - rituximab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
rituximab
Packing/Price
(vial) 1's
MIMS Class
Targeted Cancer Therapy, Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
ATC Classification
L01XC02 - rituximab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
rituximab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy, Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
ATC Classification
L01XC02 - rituximab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
benserazide hydrochloride, levodopa
Packing/Price
100's
MIMS Class
Antiparkinsonian Drugs
ATC Classification
N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
benserazide hydrochloride, levodopa
Packing/Price
100's
MIMS Class
Antiparkinsonian Drugs
ATC Classification
N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
benserazide hydrochloride, levodopa
Packing/Price
100's
MIMS Class
Antiparkinsonian Drugs
ATC Classification
N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
methoxy polyethylene glycol-epoetin beta
Packing/Price
(pre-filled syringe) 1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
(pre-filled syringe) 1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
(pre-filled syringe) 1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
(pre-filled syringe) 1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
(pre-filled syringe) 1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
pertuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC13 - pertuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
polatuzumab vedotin
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC37 - polatuzumab vedotin : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
epoetin beta
Packing/Price
6 × 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
epoetin beta
Packing/Price
6 × 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
epoetin beta
Packing/Price
6 × 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
ceftriaxone
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
ceftriaxone
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
ceftriaxone disodium
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
ceftriaxone disodium
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
ceftriaxone disodium
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
ceftriaxone disodium
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
entrectinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX14 - entrectinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
entrectinib
Packing/Price
90's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX14 - entrectinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
oseltamivir phosphate
Packing/Price
10's
MIMS Class
Antivirals
ATC Classification
J05AH02 - oseltamivir : Belongs to the class of neuraminidase inhibitors. Used in the systemic treatment of viral infections.
oseltamivir phosphate
Packing/Price
10's
MIMS Class
Antivirals
ATC Classification
J05AH02 - oseltamivir : Belongs to the class of neuraminidase inhibitors. Used in the systemic treatment of viral infections.
oseltamivir phosphate
Packing/Price
10's
MIMS Class
Antivirals
ATC Classification
J05AH02 - oseltamivir : Belongs to the class of neuraminidase inhibitors. Used in the systemic treatment of viral infections.
oseltamivir phosphate
Packing/Price
1's
MIMS Class
Antivirals
ATC Classification
J05AH02 - oseltamivir : Belongs to the class of neuraminidase inhibitors. Used in the systemic treatment of viral infections.
atezolizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy, Cancer Immunotherapy
ATC Classification
L01XC32 - atezolizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
atezolizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy, Cancer Immunotherapy
ATC Classification
L01XC32 - atezolizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
baloxavir marboxil
Packing/Price
2's
MIMS Class
Antivirals
ATC Classification
J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.
baloxavir marboxil
Packing/Price
2's
MIMS Class
Antivirals
ATC Classification
J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.
Distributed by DKSH
tocilizumab
Packing/Price
(vial) 1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
tocilizumab
Packing/Price
(vial) 1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
tocilizumab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
alectinib
Packing/Price
224's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01ED03 - alectinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC07 - bevacizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
mycophenolate mofetil
Packing/Price
100's
MIMS Class
Immunosuppressants
ATC Classification
L04AA06 - mycophenolic acid : Belongs to the class of selective immunosuppressive agents. Used to induce immunosuppression.
mycophenolate mofetil
Packing/Price
50's
MIMS Class
Immunosuppressants
ATC Classification
L04AA06 - mycophenolic acid : Belongs to the class of selective immunosuppressive agents. Used to induce immunosuppression.
obinutuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC15 - obinutuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
emicizumab
Packing/Price
1's
MIMS Class
Haemostatics
ATC Classification
B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.
emicizumab
Packing/Price
1's
MIMS Class
Haemostatics
ATC Classification
B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.
emicizumab
Packing/Price
1's
MIMS Class
Haemostatics
ATC Classification
B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.
emicizumab
Packing/Price
1's
MIMS Class
Haemostatics
ATC Classification
B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC03 - trastuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC03 - trastuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC03 - trastuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
trastuzumab emtansine
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC14 - trastuzumab emtansine : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
trastuzumab emtansine
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC14 - trastuzumab emtansine : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
rituximab
Packing/Price
(vial) 2 × 1's
MIMS Class
Targeted Cancer Therapy, Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
ATC Classification
L01XC02 - rituximab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
rituximab
Packing/Price
(vial) 1's
MIMS Class
Targeted Cancer Therapy, Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
ATC Classification
L01XC02 - rituximab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
rituximab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy, Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
ATC Classification
L01XC02 - rituximab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
benserazide hydrochloride, levodopa
Packing/Price
100's
MIMS Class
Antiparkinsonian Drugs
ATC Classification
N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
benserazide hydrochloride, levodopa
Packing/Price
100's
MIMS Class
Antiparkinsonian Drugs
ATC Classification
N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
benserazide hydrochloride, levodopa
Packing/Price
100's
MIMS Class
Antiparkinsonian Drugs
ATC Classification
N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
methoxy polyethylene glycol-epoetin beta
Packing/Price
(pre-filled syringe) 1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
(pre-filled syringe) 1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
(pre-filled syringe) 1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
(pre-filled syringe) 1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
methoxy polyethylene glycol-epoetin beta
Packing/Price
(pre-filled syringe) 1's
MIMS Class
Haematopoietic Agents
ATC Classification
B03XA03 - methoxy polyethylene glycol-epoetin beta : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
pertuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC13 - pertuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
polatuzumab vedotin
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC37 - polatuzumab vedotin : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
epoetin beta
Packing/Price
6 × 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
epoetin beta
Packing/Price
6 × 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
epoetin beta
Packing/Price
1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
epoetin beta
Packing/Price
6 × 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
B03XA01 - erythropoietin : Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
ceftriaxone
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
ceftriaxone
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
ceftriaxone disodium
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
ceftriaxone disodium
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
ceftriaxone disodium
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
ceftriaxone disodium
Packing/Price
1's
MIMS Class
Cephalosporins
ATC Classification
J01DD04 - ceftriaxone : Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
entrectinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX14 - entrectinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
entrectinib
Packing/Price
90's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX14 - entrectinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
oseltamivir phosphate
Packing/Price
10's
MIMS Class
Antivirals
ATC Classification
J05AH02 - oseltamivir : Belongs to the class of neuraminidase inhibitors. Used in the systemic treatment of viral infections.
oseltamivir phosphate
Packing/Price
10's
MIMS Class
Antivirals
ATC Classification
J05AH02 - oseltamivir : Belongs to the class of neuraminidase inhibitors. Used in the systemic treatment of viral infections.
oseltamivir phosphate
Packing/Price
10's
MIMS Class
Antivirals
ATC Classification
J05AH02 - oseltamivir : Belongs to the class of neuraminidase inhibitors. Used in the systemic treatment of viral infections.
oseltamivir phosphate
Packing/Price
1's
MIMS Class
Antivirals
ATC Classification
J05AH02 - oseltamivir : Belongs to the class of neuraminidase inhibitors. Used in the systemic treatment of viral infections.
atezolizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy, Cancer Immunotherapy
ATC Classification
L01XC32 - atezolizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
atezolizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy, Cancer Immunotherapy
ATC Classification
L01XC32 - atezolizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
baloxavir marboxil
Packing/Price
2's
MIMS Class
Antivirals
ATC Classification
J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.
baloxavir marboxil
Packing/Price
2's
MIMS Class
Antivirals
ATC Classification
J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in